Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout
Tsel' issledovaniya. Vyyavit' vozrastnye osobennosti metabolicheskogo sindroma (MS) u bol'nykh podagroy. Material i metody. V issledovanie vklyucheny 202 muzhchiny, stradayushchikh podagroy (kriterii S.L. Wallace). Laboratornye issledovaniya provodili posle kupirovaniya pristupa artri...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2007-09-01
|
| Series: | Современная ревматология |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/121 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849303431857045504 |
|---|---|
| author | V A Nasonova M S Eliseev V G Barskova V A Nasonova M S Yeliseyev V G Barskova |
| author_facet | V A Nasonova M S Eliseev V G Barskova V A Nasonova M S Yeliseyev V G Barskova |
| author_sort | V A Nasonova |
| collection | DOAJ |
| description | Tsel' issledovaniya. Vyyavit' vozrastnye osobennosti metabolicheskogo sindroma (MS) u bol'nykh podagroy. Material i metody. V issledovanie vklyucheny 202 muzhchiny, stradayushchikh podagroy (kriterii S.L. Wallace). Laboratornye issledovaniya provodili posle kupirovaniya pristupa artrita. U vsekh bol'nykh otsenivali antropometricheskie pokazateli, syvorotochnye urovni mochevoy kisloty, pokazateli lipidnogo obmena. MS diagnostirovali na osnovanii rabochikh kriteriev ekspertov Natsional'nogo instituta zdorov'ya SShA (ATR III). Insulinorezistentnost' (IR) otsenivali s pomoshch'yu indeksa NOMA (Homeostasis Model Assessment). Bol'nye byli raspredeleny na gruppy (<40 let, 40-49 let, 50-59let i ≥60 let). Rezul'taty issledovaniya. MS diagnostirovan u 67,8% bol'nykh podagroy. Chastota vyyavleniya MS v gruppakh byla sopostavimoy (65% - u bol'nykh <40 let, 70% - u bol'nykh 40-49 let, 64% - u bol'nykh 50-59 let i 73% - u bol'nykh ≥60 let). Vyyavlena pryamaya korrelyatsiya vozrasta s SAD (R=0,24, p=0,0009), DAD (R=0,32, p<0,0001), syvorotochnym urovnem glyukozy (R=0,22, p=0,0083) i obratnaya korrelyatsiya vozrasta s massoy tela (R= -0,28, p=0,0007) i syvorotochnym urovnem triglitseridov (R= -0,20, p=0,0083). Zaklyuchenie. Chastota vyyavleniya u bol'nykh podagroy MS i IR ne zavisit ot vozrasta. Polucheny dannye, svidetel'stvuyushchie o nalichii vozrastnykh osobennostey MS u bol'nykh podagroy: u molodykh bol'nykh nablyudaetsya bol'shaya vyrazhennost' ozhireniya i gipertriglitseridemii, u pozhilykh narastaet chastota arterial'noy gipertenzii i giperglikemii. |
| format | Article |
| id | doaj-art-10f63badc1904fefb7ac80161c41e620 |
| institution | Kabale University |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2007-09-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-10f63badc1904fefb7ac80161c41e6202025-08-20T03:59:57ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2007-09-0111313610.14412/1996-7012-2007-4361426Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with goutV A NasonovaM S EliseevV G BarskovaV A NasonovaM S YeliseyevV G BarskovaTsel' issledovaniya. Vyyavit' vozrastnye osobennosti metabolicheskogo sindroma (MS) u bol'nykh podagroy. Material i metody. V issledovanie vklyucheny 202 muzhchiny, stradayushchikh podagroy (kriterii S.L. Wallace). Laboratornye issledovaniya provodili posle kupirovaniya pristupa artrita. U vsekh bol'nykh otsenivali antropometricheskie pokazateli, syvorotochnye urovni mochevoy kisloty, pokazateli lipidnogo obmena. MS diagnostirovali na osnovanii rabochikh kriteriev ekspertov Natsional'nogo instituta zdorov'ya SShA (ATR III). Insulinorezistentnost' (IR) otsenivali s pomoshch'yu indeksa NOMA (Homeostasis Model Assessment). Bol'nye byli raspredeleny na gruppy (<40 let, 40-49 let, 50-59let i ≥60 let). Rezul'taty issledovaniya. MS diagnostirovan u 67,8% bol'nykh podagroy. Chastota vyyavleniya MS v gruppakh byla sopostavimoy (65% - u bol'nykh <40 let, 70% - u bol'nykh 40-49 let, 64% - u bol'nykh 50-59 let i 73% - u bol'nykh ≥60 let). Vyyavlena pryamaya korrelyatsiya vozrasta s SAD (R=0,24, p=0,0009), DAD (R=0,32, p<0,0001), syvorotochnym urovnem glyukozy (R=0,22, p=0,0083) i obratnaya korrelyatsiya vozrasta s massoy tela (R= -0,28, p=0,0007) i syvorotochnym urovnem triglitseridov (R= -0,20, p=0,0083). Zaklyuchenie. Chastota vyyavleniya u bol'nykh podagroy MS i IR ne zavisit ot vozrasta. Polucheny dannye, svidetel'stvuyushchie o nalichii vozrastnykh osobennostey MS u bol'nykh podagroy: u molodykh bol'nykh nablyudaetsya bol'shaya vyrazhennost' ozhireniya i gipertriglitseridemii, u pozhilykh narastaet chastota arterial'noy gipertenzii i giperglikemii.https://mrj.ima-press.net/mrj/article/view/121 |
| spellingShingle | V A Nasonova M S Eliseev V G Barskova V A Nasonova M S Yeliseyev V G Barskova Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout Современная ревматология |
| title | Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout |
| title_full | Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout |
| title_fullStr | Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout |
| title_full_unstemmed | Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout |
| title_short | Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout |
| title_sort | impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout |
| url | https://mrj.ima-press.net/mrj/article/view/121 |
| work_keys_str_mv | AT vanasonova impactofageonthefrequencyandmagnitudeofthesignsofmetabolicsyndromeinpatientswithgout AT mseliseev impactofageonthefrequencyandmagnitudeofthesignsofmetabolicsyndromeinpatientswithgout AT vgbarskova impactofageonthefrequencyandmagnitudeofthesignsofmetabolicsyndromeinpatientswithgout AT vanasonova impactofageonthefrequencyandmagnitudeofthesignsofmetabolicsyndromeinpatientswithgout AT msyeliseyev impactofageonthefrequencyandmagnitudeofthesignsofmetabolicsyndromeinpatientswithgout AT vgbarskova impactofageonthefrequencyandmagnitudeofthesignsofmetabolicsyndromeinpatientswithgout |